SCHEMBL3479774

SCHEMBL3479774

CN1CCN(c2cc(F)cc(F)c2)c2ccc(-n3cccn3)cc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.38
HSD11B1 P28845 1/20 0.36
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
KDM1A O60341 2/20 0.34
NOTUM Q6P988 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA10 Q9GZZ6 1/20 0.34
CHRNA9 Q9UGM1 1/20 0.34
CRHR1 P34998 2/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CHRM1 P11229 2/20 0.33
F10 P00742 1/20 0.33
SCN5A Q14524 1/20 0.33
LMNA P02545 1/20 0.33
AVPR2 P30518 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235491 0.93 SCN9A (0.41) SCN9AHSD11B1CCNA2CDK2CDK5
SCHEMBL3479720 0.88 CCNA2 (0.38) SCN9AHSD11B1CCNA2CDK2CDK5
SCHEMBL3479666 0.87 DRD2 (0.40) SCN9ANOTUMCHRNA7CHRNA10CHRNA9
SCHEMBL3236117 0.85 NOTUM (0.50) SCN9ANOTUMCHRNA7CHRNA10CHRNA9
SCHEMBL3479528 0.83 HTR3A (0.45) SCN9ACCNA2CDK2CDK5CDK5R1
SCHEMBL3229454 0.82 HSD11B1 (0.36) SCN9AHSD11B1KDM1AKDM4EALDH1A1
SCHEMBL3479590 0.81 HRH3 (0.40) SCN9AALDH1A1L3MBTL1F10CYP3A4
SCHEMBL3479763 0.80 GAA (0.47) SCN9AKDM4EALDH1A1L3MBTL1LMNA
SCHEMBL3479743 0.79 ALDH1A1 (0.49) SCN9ANOTUMALDH1A1L3MBTL1LMNA
SCHEMBL3234584 0.77 HRH4 (0.41) SCN9AALDH1A1L3MBTL1F10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885HSD11B1 482/4885CCNA2 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.